Clinical Trials on Pregnancy, Ovarian

Total 55325 results

Biocity Biopharmaceutics Co., Ltd.

Not yet recruiting

SC0191 Plus Chemotherapy in Advanced Ovarian Canceradvanced Ovarian Cancer

Advanced Ovarian Cancer | Serous Ovarian Cancer
Radboud University Medical Center

Recruiting

NEOadjuvant Dendritic Cell Vaccination for Ovarian Cancer (NEODOC)

Epithelial Ovarian Cancer | Ovarian Carcinoma

Netherlands
UMC Utrecht
University Medical Center Groningen; Erasmus Medical Center; Catharina Ziekenhuis... and other collaborators

Unknown

Pheno- & Genotyping POF (WHO III)

Premature Ovarian Failure (POF) | Incipient Ovarian Failure | Poor Response After Ovarian Hyperstimulation | Early Menopause | Hypergonadotropic Amenorrhea

Netherlands
Affiliated Hospital of Nantong University

Enrolling by invitation

Study on the Efficacy and Safety of Chiglitazar Sodium in PCOS With T2DM

T2D | PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries

China
Antalya IVF

Withdrawn

The Effect of a Dual Trigger on Intracytoplasmic Sperm Injection (ICSI) Reproductive Outcomes

Pregnancy | Ovarian Hyperstimulation Syndrome

Turkey
GlaxoSmithKline

Completed

Combination Study Of SB-485232 (Interleukin 18) And Doxil For Advanced Stage Epithelial Ovarian Cancer

Neoplasms, Ovarian

United States
Life Research Technologies GmbH

Unknown

Safety of Active Immunotherapy in Subjects With Ovarian Cancer

Ovarian Epithelial Cancer

Austria, Hungary
Gynecologic Oncology Group
National Cancer Institute (NCI)

Recruiting

Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer

Stage IIIA Ovarian Cancer | Stage IIIB Ovarian Cancer | Stage IIIC Ovarian Cancer | Stage IV Ovarian Cancer

United States
Instituto Valenciano de Infertilidad, IVI VALENCIA

Completed

Luteinizing Hormone (LH) Supplementation in Gonadotropin-releasing Hormone (GnRH) Antagonist Cycles

Ovarian Stimulation

Spain
Sorlandet Hospital HF
University of Surrey

Completed

Single Versus Conventional Laparoscopy for Benign Adnexal Disease

Ovarian Cyst

Norway
Shandong Provincial Hospital
Shandong University

Completed

A Random Clinical Trial (RCT) of the Impact of Electrocoagulation on Ovarian Reserve

Ovarian Cyst

China
Assistance Publique - Hôpitaux de Paris

Completed

Parental Project and Premature Ovarian Insufficiency (ParentIOP)

Infertility | Primary Ovarian Insufficiency

France
Benha University

Completed

Cabergoline Versus Calcium Infusion in Ovarian Hyperstimulation Syndrome Prevention

Ovarian Hyperstimulation

Egypt
Eugonia

Completed

Modified Natural Cycle Offers a Chance of Pregnancy in Patients With Poor Response and High Basal FSH

Infertility | Premature Ovarian Failure

Greece
Eugonia

Completed

Flexible GnRH Antagonist vs Flare up GnRH Agonist Protocol in Poor Responders

Infertility | Premature Ovarian Failure

Greece
iOMEDICO AG

Recruiting

Registry Platform Ovarian and Endometrial Cancer (SMARAGD)

Carcinoma | Ovarian Cancer | Endometrial Neoplasms | Endometrial Cancer | Ovary Neoplasm | Neoplasm, Ovarian | Carcinoma, Ovarian

Germany
AbbVie
Gynecologic Oncology Group;Australia New Zealand Gynaecological Oncology...

Terminated

Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Adults With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (VELIA)

Ovarian Cancer | Ovarian Neoplasm

United States, Australia, Brazil, Denmark, Israel, Japan, Korea, Republic of, New Zealand, Poland, Spain, United Kingdom
Seoul National University Hospital
Samsung Medical Center; Takeda; Asan Medical Center; Yonsei University

Not yet recruiting

PARP Inhibitor Oral Maintenance in Low-Risk Ovarian Cancer (POLO)

Ovarian Cancer | Epithelial Ovarian Cancer | Ovarian Cancer Stage IV | Ovarian Cancer Stage III
Northwell Health

Withdrawn

In Vitro Maturation (IVM) of Human Oocytes (IVM)

Polycystic Ovarian Syndrome (PCOS) | Patients Sensitive to Exogenous Gonadotropins | Ovarian Hyper Stimulation Syndrome (OHSS)

United States
Grupo Español de Tumores Huérfanos e Infrecuentes
Astellas Pharma Inc; Apices Soluciones S.L.

Completed

Enzalutamide in Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors: GREKO III Study (GREKO III)

Ovarian Cancer

Spain
Société d'Imagerie de la Femme

Unknown

EURAD-MR Classification : European Multicenter Study (EURAD)

Ovarian Tumor

United Kingdom, France, Portugal, Austria, Croatia, Italy, Serbia, Switzerland
M.D. Anderson Cancer Center
TAP Pharmaceutical Products Inc.

Completed

GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients

Amenorrhea | Premature Ovarian Failure | Ovarian Function Insufficiency

United States
Ciphergen Biosystems

Completed

Assess Cancer in Ovarian Tumors With Biomarkers.

Ovarian Tumor

United States
University of Colorado, Denver
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Recruiting

Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome (RESTORE)

Obese | PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries

United States
Erasmus Medical Center
Waterloo Foundation

Not yet recruiting

Online Brief CBT Intervention for Women With PCOS (How2deal)

Depression, Anxiety | Self Esteem | PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries

Netherlands
Ain Shams Maternity Hospital

Unknown

Routine Hysteroscopy in IVF/ICSI Cycles in Patients With Primary Unexplained Infertility

Infertility | Pregnancy | Ovarian Hyperstimulation | Primary Infertility Unspecified
Chinese University of Hong Kong

Recruiting

Clinical Application of Serum Anti-Müllerian Hormone (AMH) Measurements

Polycystic Ovarian Syndrome | Fertility Issues | Premature Ovarian Insufficiency | Anti-Müllerian Hormone

Hong Kong
Gynaecologisch Oncologisch Centrum Zuid
Amsterdam UMC, location VUmc; The Netherlands Cancer Institute; Leiden University... and other collaborators

Recruiting

CADx - Radiomics to Distinguish the Origin of Ovarian Tumors (CADx)

Ovarian Cancer

Netherlands
Centre Francois Baclesse

Recruiting

Constitution of ex Vivo Ovarian Tumor Models for the Validation of the Interest of Innovative Therapies and the Search for Tumor or Circulating Biomarkers Predictive of Treatment Response (OVAREX)

Ovarian Cancer

France
University of Wisconsin, Madison

Completed

EURAD MRI Classification of US Indeterminate Adnexa Lesions

Ovarian Tumor

United States
Fuda Cancer Hospital, Guangzhou
University of Michigan

Completed

Safety and Effectivity Immunotherapy to Treat Ovarian Cancer With Cancer Stem Cells Vaccine

Neoplasms,Ovarian

China
Centre Francois Baclesse
GRECAN

Completed

Ex Vivo Evaluation of the Interest of the Association of Platinum With a Molecule BH3-mimetic ABT-737 in Samples of Ovarian Tumors (ABT737 exvivo)

Ovarian Cancer

France
Cybrexa Therapeutics

Not yet recruiting

A Study of CBX 12 in Subjects With Platinum Resistant or Refractory Ovarian Cancer

Platinum-resistant Ovarian Cancer | Refractory Ovarian Carcinoma
Tesaro, Inc.
European Network of Gynaecological Oncological Trial Groups (ENGOT)

Active, not recruiting

A Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care (SOC) Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer (FIRST)

Ovarian Neoplasms | Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma

United States, Netherlands, Spain, Finland, Italy, Poland, Belgium, Canada, France, Germany, Romania, Ukraine, Norway, United Kingdom, Israel, Greece, Denmark, Belarus, Czechia
University of Washington
Minnesota Ovarian Cancer Alliance

Terminated

Lavage of the Uterine Cavity for Diagnosis of Ovarian Cancer

Stage III Ovarian Cancer AJCC v8 | Stage IIIA Ovarian Cancer AJCC v8 | Stage IIIA1 Ovarian Cancer AJCC v8 | Stage IIIA2 Ovarian Cancer AJCC v8 | Stage IIIB Ovarian Cancer AJCC v8 | Stage IIIC Ovarian Cancer AJCC v8 | Stage IV Ovarian Cancer AJCC v8 | Stage IVA Ovarian Cancer AJCC v8 | Stage IVB Ovarian... and other conditions

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Survivorship Care Planning in Improving Quality of Life in Survivors of Ovarian Cancer

Cancer Survivor | Stage IIIA Ovarian Epithelial Cancer | Stage IIIB Ovarian Epithelial Cancer | Stage IIIC Ovarian Epithelial Cancer | Stage IIA Ovarian Epithelial Cancer | Stage IIB Ovarian Epithelial Cancer | Stage IIC Ovarian Epithelial Cancer | Stage IA Ovarian Epithelial Cancer | Stage IB Ovarian... and other conditions

United States
Assaf-Harofeh Medical Center

Recruiting

Gonadotropin Releasing Hormone Agonist (GnRHa) Versus Estrogen and Progesterone for Luteal Support in High Responders

Ovarian Hyperstimulation Syndrome | Miscarriage | Pregnancy Early

Israel
Fondazione Policlinico Universitario Agostino Gemelli...

Recruiting

Ovarian Tumor Organotypic Slices Cultures for functionAl Drug Testing and Therapy Response Prediction (TOSCA)

Ovarian Cancer

Italy
University of Udine

Recruiting

Tumor Microenvironment in Ovarian Cancer (MICO)

Ovarian Cancer Stage IV | Ovarian Cancer Stage III

Italy
University Health Network, Toronto

Not yet recruiting

Predicting Outcome of Cytoreduction in Advanced Ovarian Cancer, Using a Machine Learning Algorithm and Patterns of Disease Distribution at Laparoscopy (PREDAtOOR) (PREDAtOOR)

Ovarian Cancer Stage IV | Ovarian Cancer Stage III
City of Hope Medical Center
National Cancer Institute (NCI)

Recruiting

Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer

Platinum-Resistant Ovarian Carcinoma

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

PET/MR Versus CECT Scans in Imaging Patients With Ovarian Cancer or Highly Suspected Ovarian Cancer

Ovarian Carcinoma | Malignant Ovarian Neoplasm

United States
AstraZeneca

Completed

C-PATROL - Non-interventional Study (NIS) to Collect Clinical and Patient Reported Outcome Data in an Olaparib Treated BRCAm+ PSR Ovarian Cancer Population (C-PATROL)

Ovarian Cancer, Hereditary Ovarian Cancer Syndrome

Germany
ImmunoVaccine Technologies, Inc. (IMV Inc.)

Terminated

Maveropepimut-S (MVP-S) and Low-Dose CPA in Patients With Platinum-Resistant Ovarian Cancer (AVALON)

Platinum-resistant Epithelial Ovarian Cancer

United States, Canada, Puerto Rico
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Levonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian Cancer

Ovarian Carcinoma

United States
Memorial Sloan Kettering Cancer Center

Recruiting

A Study of Intra-operative Imaging in Women With Ovarian Cancer

Ovarian Cancer | Ovarian Carcinoma

United States
Sunnybrook Health Sciences Centre
GlaxoSmithKline

Recruiting

Alternative Dosing Of Niraparib To Decrease Dose Interruption In First Line Maintenance Treatment For Ovarian Cancer

Ovarian Cancer | Stage IV Ovarian Cancer | High Grade Ovarian Serous Adenocarcinoma | Stage III Ovarian Cancer

Canada
CanariaBio Inc.
Korean Cancer Study Group

Recruiting

Oregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer

Ovarian Cancer Stage IV | Ovarian Cancer Stage III | Ovarian Cancer by FIGO Stage

Korea, Republic of
Fundación IVI
Instituto Valenciano de Infertilidad, IVI VALENCIA; Hospital Universitario... and other collaborators

Completed

4-step ASCOT in POI Women to Promote Follicular Rescue

Premature Ovarian Insufficiency

Spain
Hospices Civils de Lyon

Completed

Low Grade Serous Ovarian Carcinoma and Uterine Involvement : Should Hysterectomy be the Rule (LOGYST)

Serous Ovarian Carcinoma | Low Grade Serous Ovarian Carcinoma

France

Clinical Trials on Pregnancy, Ovarian

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Poland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations